{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:46:15Z","timestamp":1771263975539,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ahj.2014.06.020","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T19:30:28Z","timestamp":1404415828000},"page":"457-465.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c"],"prefix":"10.1016","volume":"168","clinical-trial-number":[{"clinical-trial-number":"nct01425359","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01472185","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01494987","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01555164","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Suzanne V.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Olmsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard R.","family":"Chaitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ahj.2014.06.020_bb0005","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2014.06.020_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjcard.2004.09.025","article-title":"Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris","volume":"95","author":"Rousseau","year":"2005","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2014.06.020_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahj.2014.06.020_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2014.06.020_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCOUTCOMES.108.798009","article-title":"Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial","volume":"1","author":"Arnold","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"10.1016\/j.ahj.2014.06.020_bb0030","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.06.020_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2014.2120","article-title":"Effects of Ranolazine on Quality of Life Among Patients With Diabetes Mellitus and Stable Angina","author":"Arnold","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"20","key":"10.1016\/j.ahj.2014.06.020_bb0040","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"issue":"Suppl. 4","key":"10.1016\/j.ahj.2014.06.020_bb0045","first-page":"iv6","article-title":"Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine","volume":"92","author":"Belardinelli","year":"2006","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ahj.2014.06.020_bb0050","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.2337\/db13-0420","article-title":"Increased persistent sodium current Due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart","volume":"62","author":"Lu","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ahj.2014.06.020_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2014.06.020_bb0060","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","article-title":"Monitoring the quality of life in patients with coronary artery disease","volume":"74","author":"Spertus","year":"1994","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2014.06.020_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.06.020_bb0070","first-page":"1","article-title":"Cardiovascular survey methods","volume":"56","author":"Rose","year":"1968","journal-title":"Monogr Ser World Health Organ"},{"issue":"6","key":"10.1016\/j.ahj.2014.06.020_bb0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.ahj.2014.06.020_bb0080","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.ahj.2014.06.020_bb0085","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","article-title":"Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2014.06.020_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehi495","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2006","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.06.020_bb0095","first-page":"A234","article-title":"Inhibition of glucagon secretion in rat pancreatic islets via Na+ channels: mechanism of anti-diabetic effect of ranolazine","volume":"62","author":"Yang","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.06.020_bb0100","first-page":"A272","article-title":"The mechanism of the anti-diabetic effect of ranolazine: inhibition of glucagon secretion in rat pancreatic islets via Na+ channel blockade","volume":"62","author":"Kahlig","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.06.020_bb0105","first-page":"A227","article-title":"Ranolazine inhibits glucogon secretion from human pancreatic islets via blockade of the Nav1.3 channels in alpha-cells","volume":"62","author":"Dhalla","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.06.020_bb0110","first-page":"A280","article-title":"Na channel blockers exert anti-diabetic effects via lowering glucagon levels in ZDF diabetic rats","volume":"62","author":"Ning","year":"2013","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2014.06.020_bb0115","first-page":"A235","article-title":"Ranolazine suppresses exaggerated postprandial glucagon response in STZ-induced diabetic rats","volume":"62","author":"Ning","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ahj.2014.06.020_bb0120","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.yjmcc.2012.02.006","article-title":"Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart","volume":"52","author":"Nishio","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"10.1016\/j.ahj.2014.06.020_bb0125","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1161\/CIRCULATIONAHA.112.105320","article-title":"Ca2+\/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac disease","volume":"126","author":"Koval","year":"2012","journal-title":"Circulation"},{"issue":"31","key":"10.1016\/j.ahj.2014.06.020_bb0130","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ahj.2014.06.020_bb0135","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.107.188629","article-title":"Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"117","author":"Deedwania","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.06.020_bb0140","author":"Department of Health and Human Services"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314004049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870314004049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:52:27Z","timestamp":1757569947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870314004049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0002870314004049"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.06.020","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}